Clinical trialNCT03380026CompletedPhase 2Interventional

Mechlorethamine Induced Contact Dermatitis Avoidance Study

SponsorRochester Skin Lymphoma Medical Group, PLLCEnrollment28Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma Stage IFolliculotropic Mycosis FungoidesGranulomatous Slack SkinMycosis FungoidesMycosis Fungoides Variant+2 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a two-arm, open-label study that aims to compare the incidence and severity of the most common adverse reactions, particularly contact dermatitis, when Valchlor is used alone or in conjunction with triamcinolone ointment 0.1% in early stage MF subjects (Stage IA and IB) for a period of 4 months.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brian Poligone, MD, PhD
Rochester Skin Lymphoma Medical Group, PLLC
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Rochester Skin Lymphoma Medical Group, Pllc
Fairport, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Triamcinolone →Valchlor 0.016 % Topical Gel

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Dec 2017
Primary completion: 3 Aug 2020
Completion: 13 Dec 2020
Last update posted: 24 Nov 2021
Registered enrollment: 28
Registry id: NCT03380026

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.